drugset / Trial / NCT00364442

Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics

NCT00364442

Phase 1 Completed 12 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

A new formulation of Fluticasone propionate/Salmeterol comparing a lower dose of fluticasone propionate and salmeterol was compared with concurrent administration of fluticasone propionate and salmeterol. Administration occurred over 14 days and tolerability, PK (pharmacokinetic) and PD (pharmacodynamic) measurements were performed.

Timeline

Start
2005-01-28
Primary completion
2005-04-13
Completion
2005-04-13

Publications

  • Background This study has not been published in the scientific literature.

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified Inhaled
Subject Salmeterol Other / unclassified Inhaled

Indications